title: How can donors with a previous malignancy be evaluated?
authors.affiliation: The University of Cincinnati, Division of Transplantation, Cincinnati, OH, USA. Joseph.buell@uc.edu <Joseph.buell@uc.edu>
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Buell
authors.forename: Rita R
authors.initials: RR
authors.lastname: Alloway
authors.forename: E
authors.initials: E
authors.lastname: Steve Woodle
mesh_terms: D006801:Humans; D015994:Incidence; D017093:Liver Failure / Q000453:epidemiology* / Q000601:surgery*; D016031:Liver Transplantation / Q000706:statistics & numerical data*; D009369:Neoplasms / Q000453:epidemiology*; D012307:Risk Factors; D014019:Tissue Donors / Q000706:statistics & numerical data* / Q000600:supply & distribution